Zacks: Clinigen Group Plc (CLIGF) Given Consensus Rating of “Strong Buy” by Brokerages
Shares of Clinigen Group Plc (NASDAQ:CLIGF) have received a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation.
Zacks has also given Clinigen Group Plc an industry rank of 96 out of 265 based on the ratings given to its competitors.
Separately, Zacks Investment Research downgraded shares of Clinigen Group Plc from a “buy” rating to a “hold” rating in a research note on Wednesday, May 24th.
Shares of Clinigen Group Plc (CLIGF) opened at 13.90 on Friday. Clinigen Group Plc has a 12-month low of $8.70 and a 12-month high of $13.90. The stock has a market capitalization of $1.60 billion and a P/E ratio of 86.34.
TRADEMARK VIOLATION NOTICE: This article was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/09/09/zacks-clinigen-group-plc-cligf-given-consensus-rating-of-strong-buy-by-brokerages.html.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Clinigen Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.